Here is, of course, the new company report on Atria by Rauli and Pauli 
Atria’s Q1 results were close to our expectations, and the company reiterated its guidance for a full-year earnings improvement. However, we believe that accelerating inflation will weigh on earnings, which is why we slightly lowered our estimates for this year. In our view, the stock is neutrally valued (e.g., 2026 P/E 11x), and the expected return remains muted. We reiterate our Reduce recommendation and lower our target price to EUR 17.5 (prev. EUR 18.5) due to lower estimates and the stock going ex-dividend.